VIRUS-INDUTsIROVANNAYa BRONKhIAL'NAYa ASTMA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Modern international and national guidance on a strategy for treatment and prevention of bronchial asthma distinguish the role of the respiratory viral infection in the strengthening of the inflammatory process in bronchial asthma. Respiratory viral infection is the most common trigger of asthma in childhood. Acute respiratory viral infection is often precede appearance of bronchial asthma. The majority of children with bronchial asthma the occurrence of the first attack suffocation due to the accession of acute respiratory infection. In 60-85 % of cases the cause of exacerbations of asthma are respiratory viruses. Recurrent respiratory infection is often caused by lack of control of asthma symptoms, despite the basic therapy. Effective anti-inflammatory drugs for the prevention of exacerbations of virus-induced bronchial asthma in children and adults at the present stage are leykotrienovyh receptor antagonists.

Full Text

Restricted Access

About the authors

V. A Bulgakova

References

  1. Геппе Н.А. Актуальность проблемы бронхиальной астмы у детей // Педиатрия им. Г.Н. Сперанского 2012. Т. 91. № 3. С. 76-82.
  2. Jackson D.J, Johnston S.L. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol 2010;125(6):1178-87.
  3. Xepapadaki P, Papadopoulos N.G. Childhood asthma and infection: virusinduced exacerbations as determinants and modifiers. Eur Respir J 2010;36:438-45.
  4. Булгакова В.А., Балаболкин И.И., Сенцова Т.Б. Респираторная вирусная инфекция у детей и подростков с аллергической патологией // Детские инфекции 2005. Т. 4. № 4. С. 17-24.
  5. Аллергологияииммунология/Подред.А.А.Баранова, Р.М. Хаитова. 3-е изд., испр. и доп. (Клинические рекомендации для педиатров). М., 2011. 256 с.
  6. Global Initiative for Asthma. GINA report, Global Strategy for Asthma Management and Prevention 2006. Available at: http://www.ginasthma.org/ [Accessed: 20 May 2008].
  7. Булгакова В.А. Бронхиальная астма и респираторные инфекции у детей. Саарбрюккен, Германия: LAP LAMBERT Academic Publishing, 2011. 292 с.
  8. Papadopoulos N.G, Xepapadaki P, Mallia P, et al. Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy 2007;62(5):457-70.
  9. Bacharier L.B. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63:5-34.
  10. Papadopoulos N.G, Arakawa H, Carlsen K-H, et al. International consensus on (ICON) pediatric asthma. Allergy 2012;67:976-97.
  11. Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000;16:1142-46.
  12. Smuts H, Workman L, Zar H.J. Role of human metapneumovirus, human coronavirus NL63 and human bocavirus in infants and young children with acute wheezing. J Med Virol 2008;80:906-12.
  13. MacDowell A.L, Bacharier L.B. Infectious triggers of asthma. Immunol Allergy Clin N Am 2005;25:45-66.
  14. Murray C.S, Simpson A, Custovic A. Allergens, viruses and asthma exacerbations. Proc Am Thorac Soc 2004;1:99-104.
  15. Gern J.E. Mechanism of virus-induced asthma. J Pediatr 2003;142:9-14.
  16. Joshi P, Kakakios A, Isaacs D. The role of respiratory syncytial virus (RSV) in the etiology of atopy and asthma. ACI Interhational 2000;12(5):213-17.
  17. Juntii H, Kokkonen J, Dunder T, et al. Association of an early respiratory syncytial virus infection and atopic allergy. Allergy 2003;58:878-84.
  18. Roman M, Calhoun W.J, Hinton K.L, et al. Respiratory syncitial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997;156:190-95.
  19. Клиническая аллергология детского возраста с неотложными состояниями / Под ред. И.И. Балаболкина, В.А. Булгаковой. М., 2011. 264 с.
  20. McKean M, Ducharme F. Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev 2000;(2):CD001107.
  21. Global Initiative for аsthma (GINA). Global strategy for asthma management and prevention. Bethesda (MD):GINA, 2010.
  22. Fal A.M, Kopec A. Status of leukotrienes in the pathophysiology of asthma. Necessity for anti-leukotrienes treatment. Pneumonol Alergol Pol 2010;78(1):68-73.
  23. Bacharier L.B, Phillips B.R, Zeiger R.S, et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J. Allergy Clin Immunol 2008;122(6):1127-35.
  24. Hakim F, Vilozni D, Adler A, et al. The effect of montelukast on bronchial hyperreactivity in preschool children. Chest 2007;131:180-86.
  25. Wahn U, Dass S.B. Review of recent results of montelukast use as a monotherapy in children with mild asthma. Clin Ther 2008;30: 1026-35.
  26. Johnston N.W, Mandhane P.J, Dai J, et al. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Pediatrics 2007;120: 702-12.
  27. Bisgaard H, Skoner D, Boza M.L, et al. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. Pediatr Pulmonol 2009;44:568-79.
  28. Кухтинова Н.В., Кондюрина Е.Г. Эффективность монтелукаста натрия в терапии различных фенотипов бронхиальной астмы у детей // Пульмонология 2011. № 1. С. 74-80.
  29. Герасимова Н.Г., Горбатов В.А., Чашина Т.Е. Применение Сингуляра в базисной терапии бронхиальной астмы у детей // Детская больница 2012. № 2. С. 56-58.
  30. Клименко В.А., Адарюкова Л.М., Плахотная О.Н. и др. Вирус-индуцированная бронхиальная астма у детей: состояние проблемы и пути решения // Астма и аллергия 2011. № 4. С. 50-7.
  31. Bisgaard H. Montelukast for Viral Respiratory Infection-induced Exacerbations of Asthma. Am J Respir Crit Care Med 2005;172(6):783-84.
  32. Балаболкин И.И., Смирнов И.Е., Ляпунов А.В. и др. Эффективность лечения монтелукастом детей с бронхиальной астмой // Вопросы современной педиатрии 2006. Т. 5. № 5. С. 35-38.
  33. Геворкян А.К., Галеева Е.А. Эффективность монтелукаста натрия у больных с бронхиальной астмой // Педиатрическая фармакология 2008. Т. 5. № 4. С. 123-25.
  34. Балаболкин И.И., Лукина О.Ф. Терапевтическая эффективность монтелукаста натрия при бронхиальной астме у детей // Пульмонология детского возраста: проблемы и решения / Под ред. Ю.Л. Мизерницкого, А.Д. Царегородцева. М., 2009. Вып. 9. С. 145.
  35. Левина Ю.Г., Намазова-Баранова Л.С. Оценка эффективности антагонистов лейкотриеновых рецепторов в терапии бронхиальной астмы у детей // Педиатрическая фармакология 2009. Т. 6. № 4. С. 84-7.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies